“PHARMACEUTICAL PERFORMANCE IN THE EVALUATION AND ADHERENCE TO PHARMACOLOGICAL TREATMENT OF TYPE 2 DIABETES MELLITUS”. REMUNOM 9, no. 1 (May 15, 2025): 1–13. Accessed April 12, 2026. https://remunom.ojsbr.com/multidisciplinar/article/view/3911.